Non-Hormonal Therapy for Endometriosis Based on Angiogenesis, Oxidative Stress and Inflammation
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Non-hormonal treatments for endometriosis are crucial, especially for women desiring pregnancy. This review explores non-hormonal therapies targeting key disease processes like angiogenesis, oxidative stress, and inflammation.
Area Of Science
- Gynecology
- Pathophysiology
Background
- Endometriosis affects 6-10% of reproductive-aged women, characterized by endometrial tissue outside the uterus.
- Its pathophysiology involves complex processes including angiogenesis, oxidative stress, and inflammation.
- Current hormonal treatments pose challenges for fertility and have side effects, necessitating alternative therapies.
Purpose Of The Study
- To provide an overview of non-hormonal treatment strategies for endometriosis.
- To focus on therapies targeting angiogenesis, oxidative stress, and inflammation.
Main Methods
- Literature review of non-hormonal endometriosis treatments.
- Analysis of biological pathways involved in endometriosis.
Main Results
- Hormonal therapies are unsuitable for women seeking pregnancy.
- Existing treatments can lead to disease recurrence and side effects.
- Non-hormonal approaches targeting key biological processes are needed.
Conclusions
- Development of non-hormonal drugs is essential for endometriosis management.
- Targeting angiogenesis, oxidative stress, and inflammation offers promising therapeutic avenues.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...